RE:RE:RE:RE:RE:Burning Questions...Ok, I stand corrected. I do think these Docs have time/talent to clean this up. We'll see how well their adjustments work for treatment two and also, once sites commence, for new enrollees.
2b7f6fab wrote: It was both light and dose but mainly dose. You tryinng to make excuse for AM? That lack of communications is laid on the researchers at Theralase.
Quattro74 wrote: Is this really a FU by the Docs/Research clinicians? I mean the phase 1 was only 6 patients. There is so much variability in patients for the DFOC here as designed. They will see even more variability, learn more how to 'fine tune' the DFOC as they move forward. To me, as I read it, the undertreatment was with the light, not the PDC 1433 dose???